Literature DB >> 19254250

CTLA-4 +49A/G polymorphism is associated with Behçet's disease in a Tunisian population.

I Ben Dhifallah1, H Chelbi, A Braham, K Hamzaoui, M H Houman.   

Abstract

The involvement of excessive T-helper cell functions in the pathogenesis of Behçet's disease (BD) has been reported. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) plays a role in T-cell downregulation. In this report, we investigated the possible association between BD patients and the CTLA-4 +49A/G polymorphism in Tunisian population. A total of 135 Tunisian BD patients and 151 healthy blood donors from the same geographic area were genotyped by polymerase chain reaction for the CTLA-4 +49 A/G polymorphism. A highly significant difference between Tunisian BD patients and healthy controls was found regarding the distribution of CTLA-4 +49 A allele [P < 10(-7); chi(2) = 75.63; odds ratio (OR) = 4.63; 95% confidence interval (CI) = 3.20-6.72] and genotype frequencies (P < 10(-7); chi(2) = 71.02). Furthermore, in the BD group, the A allele was predominant in males (76.3%) when compared with females (62%), (P = 0.014; chi(2) = 5.97; OR = 1.99; 95% CI = 1.10-3.59). No relationship was found between the studied genotype and clinical manifestations. Our results show a gene dose effect of the A allele on the BD. The A allele exerts a stronger effect on disease susceptibility in males compared with females.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254250     DOI: 10.1111/j.1399-0039.2008.01186.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

1.  CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

Review 2.  The genetics of Behçet's disease in a Chinese population.

Authors:  Shengping Hou; Aize Kijlstra; Peizeng Yang
Journal:  Front Med       Date:  2012-11-15       Impact factor: 4.592

Review 3.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

4.  The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease.

Authors:  Sahar M Abdel Galil; Hoda A Hagrass
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

5.  TIM-3 genetic variants and risk of Behçet disease in the Iranian population.

Authors:  Mitra Ataei; Farinaz Behfarjam; Zohreh Jadali
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.